EMA to Juggle Brexit and New Quality and Safety Guidelines Next Year

Drug GMP Report
In 2018, the European Medicines Agency’s quality and safety working groups intend to tackle several new guidelines, covering the sterilization of products and containers, risk-based prevention of cross contamination in manufacturing and requirements for products containing a device delivery component.

To View This Article:


Subscribe To Drug GMP Report